Experimental · 4.9/10
5-Amino-1MQ
5-Amino-1MQ is a synthetic NNMT-inhibitor research compound that cut fat mass in obese mice and raised NAD+ in cultured fat cells (Neelakantan 2018), but it has zero human trials. Oral 50 to 150 mg is the only route with pharmacokinetic support; injectable microgram doses are likely too low to work. Read the full breakdown →
The prediction game
Where does 5-Amino-1MQ go in 12 months?
Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.
The Crowd’s Call
Early scout calls are locked in
Be the first scout on record for 5-Amino-1MQ. Permanent credit on this page, plus points when your call resolves.
One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
Same as above — one verification covers all your entries here.
For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.